6021 - 6030 of 9033 Results
Title
Year
-
OPENTitle: LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ciliogenesis blockadeJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 4Issue #: 5Start Page: e202101050End Page: e202101050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202101050Best OA location URL: https://www.life-science-alliance.org/content/lsa/4/5/e202101050.full.pdfCitation Count: 54
-
OPENTitle: Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality MappingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 554660End Page: 554660Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.554660Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.554660/pdfCitation Count: 9
-
OPENTitle: Single-cell multiomic analyses sheds light on mitochondrial mutational selectionJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 55Issue #: 7Start Page: 1083End Page: 1085Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41588-023-01436-5Best OA location URL: https://doi.org/10.1038/s41588-023-01436-5Citation Count: 2
- Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies2017RESTRICTEDTitle: Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesJournal Name: Clinica Chimica ActaPublisher: Elsevier BVVol: 466Issue #:Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cca.2017.01.010Citation Count: 30
-
OPENTitle: Hippocampal-striatal interaction in Parkinson’s disease with mild cognitive impairmentJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 14Issue #:Start Page: 100443End Page: 100443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.prdoa.2026.100443Best OA location URL: https://doi.org/10.1016/j.prdoa.2026.100443Citation Count: 0
-
OPENTitle: Genetic modulation of mitochondrial NAD+ regeneration does not prevent dopaminergic neuron dysfunction caused by mitochondrial complex I impairmentJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 1650462End Page: 1650462Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2025.1650462Best OA location URL: https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1650462/pdfCitation Count: 1
-
OPENTitle: Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicityJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 195Issue #:Start Page: 119034End Page: 119034Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopha.2026.119034Best OA location URL: https://doi.org/10.1016/j.biopha.2026.119034Citation Count: 0
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 69
-
OPENTitle: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and InternalizationJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 291Issue #: 9Start Page: 4374End Page: 4385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m115.705095Best OA location URL: http://www.jbc.org/article/S0021925820435859/pdfCitation Count: 163
- Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?2020RESTRICTEDTitle: Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 330Issue #:Start Page: 113357End Page: 113357Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2020.113357Citation Count: 21